News

Sensorimotor retraining aims to correct a disruption within the nervous system that causes lower back pain by changing how people process sensory information from their back.

Researchers have discovered that hepatocellular carcinomas, the main type of liver cancer, modify their metabolism of the amino acid arginine which renders them susceptible to disruptions in its supply.

A 3D tumor model around the size of a pencil eraser could help treat glioblastoma with personalized therapies by accurately replicating the tumor microenvironment.

Researchers have succeeded in using a plant-derived nutrient supplement to shrink breast cancer tumors in preclinical models.

Researchers report that a gene therapy approach measurably delayed disease onset in humanized mouse and rat models of an inherited form of ALS that runs in families.

A new vaccine for tuberculosis has been shown to be safe for newborns and has fewer side effects than the current vaccine.

A new human genomics study led by Yale scientists has identified genetic risk factors for opioid use disorder (OUD) and related substance use disorders according to a new large-scale genome-wide association study – increasing the number of risk genes known from 1 to 19.

A new method of delivering an immunotherapy directly to a tumor has been developed, composed of a gelatin/nanoplatelet mixture for effective drug delivery and sustained drug release.

Researchers found a mechanism by which cancers keep T cells from infiltrating tumors by sending out exosome "drones", which offers a new tool to predict how a patient might respond to checkpoint inhibitor drugs.

According to a study, epigenetic changes prevent iron-associated programmed cell death in leukemia and show a new target for treatment with experimental drugs.